Related Experiment Videos
Repeated blood donation effective in treating hyperlipidemia
1Indira Gandhi Institute of Cardiology, Juhi Nursing Home.
Insights
Repeated blood donation significantly lowers blood lipids like cholesterol and triglycerides. This non-pharmacological approach, combined with medication, proved more effective than medication alone for hyperlipidaemia patients.
Area of Science:
- Cardiology
- Metabolic Disorders
- Hematology
Background:
- Hyperlipidemia is a major risk factor for cardiovascular diseases.
- Current treatments often involve lifestyle changes and pharmacotherapy.
- Exploring non-pharmacological interventions is crucial for comprehensive management.
Purpose of the Study:
- To evaluate the effectiveness of repeated blood donation as an adjunct therapy for hyperlipidemia.
- To compare the lipid-lowering effects of gemfibrozil alone versus gemfibrozil combined with regular blood donation.
Main Methods:
- A study involving two groups of hyperlipidemia patients.
- Group A received gemfibrozil (1200 mg/day) alone for 3 months.
- Group B received gemfibrozil (1200 mg/day) plus 300 ml blood donation monthly for 3 months.
Main Results:
- Group B showed a nearly two-fold greater reduction in serum total cholesterol, LDL, and triglycerides compared to Group A.
- High-density lipoprotein (HDL) levels remained largely unchanged in both groups.
- The combination therapy demonstrated enhanced lipid-lowering efficacy.
Conclusions:
- Repeated blood donation is an effective non-pharmacological strategy to enhance lipid reduction in hyperlipidemia patients.
- This method offers a dual benefit: improved patient lipid profiles and a supply of donated blood.
- The approach may be particularly beneficial for obese individuals with hyperlipidemia.
Abstract:
Effectiveness of repeated blood donation in lowering blood lipids has been studied. Ten patients of hyperlipidaemia who donated blood 300 ml every month for 3 months and received gemfibrozil 1200 mg/day (Group B) had nearly 2 fold greater fall in serum total cholesterol, LDL and triglyceride levels in comparison to 17 patients of group A who were treated with gemfibrozil alone in similar dose for the same period. HDL level remained almost unchanged. Thus, a non-pharmacological way of treating hyperlipidaemia has emerged from this study. Moreover donated blood will be available as by-product for use by others. This method may be especially suitable in obese persons.